High-Quality Surgical Videos Lacking for Vaporization of Prostate
THURSDAY, Feb. 2, 2023 -- Few high-quality educational surgical videos are available for green-light laser vaporization of the prostate for benign prostatic hyperplasia, according to a study published in the December issue of Translational Andrology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 2, 2023 Category: Pharmaceuticals Source Type: news
5-ARIs Not Linked to Risk of Dementia Over the Long Term
(MedPage Today) -- Men taking 5α-reductase inhibitors (5-ARIs), commonly used for androgenic alopecia and benign prostatic hyperplasia (BPH), should be aware of possible adverse psychological effects, researchers warned.
In a register-based... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 22, 2022 Category: Dermatology Source Type: news
Poor Sleep Tied to Urinary, Prostate Symptoms
MONDAY, Dec. 5, 2022 -- Poor sleep quality is associated with an increased prevalence of lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH), according to a study published online Oct. 24 in Frontiers in Aging Neuroscience.
Yifan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2022 Category: Pharmaceuticals Source Type: news
Lipid Ratios Linked to Benign Prostatic Hyperplasia Risk
FRIDAY, Nov. 4, 2022 -- In the Chinese population, the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio and the total cholesterol (TC)/HDL-C ratio are associated with an increased risk for benign prostatic hyperplasia (BPH),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2022 Category: Pharmaceuticals Source Type: news
Prevalence of Benign Prostatic Hyperplasia Increasing Globally
THURSDAY, Nov. 3, 2022 -- The prevalence of benign prostatic hyperplasia is increasing globally, according to a study published online Oct. 20 in The Lancet Healthy Longevity.
Atalel Fentahun Awedew, M.D., from Addis Ababa University in Ethiopia,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 3, 2022 Category: Pharmaceuticals Source Type: news
Fall risk related to subtype-specific alpha-antagonists for benign prostatic hyperplasia: a nationwide Korean population-based cohort study - Seo JH, Han JS, Lee Y, Myong JP, Ha US.
BACKGROUND: Subtype-specific alpha-antagonists are medications commonly prescribed for lower urinary-tract symptoms, benign prostatic hyperplasia in older populations. Our study aims to investigate the association between subtype-specific alpha-antagonists... (Source: SafetyLit)
Source: SafetyLit - November 2, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Erectile Function Mostly Not Impacted by Surgery for BPH
WEDNESDAY, Sept. 21, 2022 -- Benign prostatic hyperplasia (BPH) surgery can impact sexual function, mainly involving ejaculatory function, according to a systematic review and meta-analysis recently published in European Urology Focus.
Celeste... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2022 Category: Pharmaceuticals Source Type: news
Efficacy and Safety of Dutasteride and Finasteride in BPH Efficacy and Safety of Dutasteride and Finasteride in BPH
Are these two drugs safe and effective options for the treatment of benign prostatic hyperplasia?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2022 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Aquablation Promising for Benign Prostatic Hyperplasia Aquablation Promising for Benign Prostatic Hyperplasia
Aquablation appears to be a safe and effective for treatment for lower-urinary-tract symptoms due to benign prostatic hyperplasia, regardless of prostate volume, new data show.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 9, 2022 Category: Consumer Health News Tags: Urology News Source Type: news
Association between benign prostatic hyperplasia and suicide in South Korea: a nationwide retrospective cohort study - Lee SU, Lee SH, So AH, Park JI, Lee S, Oh IH, Oh CM.
This study aims to examine the association benign prosta... (Source: SafetyLit)
Source: SafetyLit - March 14, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
FDA Approves Entadfi (finasteride and tadalafil) as a New Treatment for Benign Prostatic Hyperplasia
MIAMI, Dec. 13, 2021 (GLOBE NEWSWIRE)— Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 13, 2021 Category: Drugs & Pharmacology Source Type: news
Enlarged Prostate Doesn't Raise a Man's Odds for Cancer
Researchers report that having an enlarged prostate -- a condition called benign prostatic hyperplasia (BPH) -- may actually provide some protection from developing prostate cancer. (Source: WebMD Health)
Source: WebMD Health - August 25, 2021 Category: Consumer Health News Source Type: news
Enlarged Prostate Doesn't Raise a Man's Odds for Cancer: Study
WEDNESDAY, Aug. 25, 2021 -- Does having an enlarged prostate doom you to prostate cancer?
Far from it, a new study suggests.
Also called benign prostatic hyperplasia (BPH), the condition may actually provide some protection for men from developing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 25, 2021 Category: General Medicine Source Type: news
Complication Rates After Surgery for BPH: Real-World Data Complication Rates After Surgery for BPH: Real-World Data
Data from a large real-world study of benign prostatic hyperplasia (BPH) therapies show that 2 of 3 minimally invasive surgical therapies give TURP a run for its money.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2021 Category: Consumer Health News Tags: Urology News Source Type: news
University Hospitals urologist designated as Center for Excellence for GreenLight Laser Therapy
(University Hospitals Cleveland Medical Center) University Hospitals' Irina Jaeger, MD, received the prestigious designation as a Center of Excellence for GreenLight Laser Therapy treatment - a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. Dr. Jaeger is a urologist at UH Richmond Medical Center and UH Brainard Medical Building in Lyndhurst. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2021 Category: International Medicine & Public Health Source Type: news
